BML Inc operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares BML Inc with three other
pharmaceutical manufacturers in Asia:
Malaysian Genomics Resource Centre Berhad
sales of 4.41 million Malaysian Ringgits [US$1.38 million]
Medical & Biological Laboratories Company Limited
(7.17 billion Japanese Yen [US$67.56 million]
of which 100%
was Reagent business), and
Falco Sd Holdings Company Limited
(58.40 billion Japanese Yen [US$550.14 million]
BML Inc reported sales of ¥99.05 billion (US$933.02 million)
March of 2014.
increase of 4.7%
versus 2013, when the company's sales were ¥94.61 billion.
Sales at BML Inc have increased during each of the previous five years
(and since 2009, sales have increased a total of 28%).